https://www.scconline.com/blog/post/2022/12/07/karnataka-hc-healthcare-global-enterprises-loss-of-profit-due-to-price-regularisation-of-essential-anti-cancer-drugs-is-not-a-ground-for-judicial-review-of-a-government-policy/